THE Pharmaceutical Society of Australia (PSA) has voiced its support for Kidney Health Australia's new national plan to address surging rates of kidney disease, released yesterday on World Kidney Day.
The evidence-based paper strongly advocates for the expansion of Home Based Medicine Reviews (HMRs) as a critical screening and diagnostic tool to prevent the progression of kidney disease.
PSA backed the idea, recommending that HMRs be uncapped from the current 30 per month limit.
"The latest national statistics from Kidney Health Australia are very sobering and, as frontline health professionals, we are seeing the growing incidence and consequences of kidney disease every day," said PSA national president, Professor Mark Naunton.
"Pharmacists look forward to working with other health professionals to eliminate the incidence of kidney disease as quickly and effectively as we can," he added.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Mar 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 26
